| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.097 | 0.06 |